Recent Analyst Forecasts and Stock Ratings
MoonLake Immunotherapeutics FAQ's
MoonLake Immunotherapeutics has been rated by research analysts at RBC Capital, H.C. Wainwright, Goldman Sachs, Needham in the past 90 days.
MoonLake Immunotherapeutics has been rated by research analysts at RBC Capital, H.C. Wainwright, Goldman Sachs, Needham in the past 90 days.